The safety of volume replacement with HAES 130/0.4 during non-cardiac surgery
- VernacularTitle:非心脏外科手术患者羟乙基淀粉130/0.4注射液容量治疗的安全性
- Author:
Jing ZHAO
;
Tiehu YE
;
Qing XU
- Publication Type:Journal Article
- Keywords:
Hetastarch;
Plasma substitutes;
Non-cardiac operation
- From:
Chinese Journal of Anesthesiology
1996;0(09):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the safety of plasma volume replacement with HAES 130/0.4 during non-cardiac surgery in terms of hemodynamic stability, blood gases, hepato-renal function, blood coagulation and adverse reactions. Methods This was a five center prospective study comparing the safety and efficacy of HAES 130/0.4(6%) with HAES 200/0.5(6%)in a double-blind fashion. The selection criteria included ASA Ⅰ Ⅱ patients of both sex, aged 18-65yrs undergoing non-cardiac surgery of which the intraoperative blood loss was expected to exceed 400ml. Patients whose Hb
